# Traditional Chinese medicine’s holistic approach: regulating microglia-driven neuroinflammation for the resolution of Alzheimer’s disease

**Authors:** Jialing Yu, Xinya Bao, Chuchu Shan, Zebin Yu, Yajie Yu, Hongying Wang, Yuyan Zhang

PMC · DOI: 10.3389/fncel.2025.1691253 · Frontiers in Cellular Neuroscience · 2025-11-03

## TL;DR

This paper explores how traditional Chinese medicine may help treat Alzheimer's disease by regulating microglia, immune cells in the brain that contribute to neuroinflammation.

## Contribution

The paper provides a novel analysis of traditional Chinese medicine's strategies for modulating microglia in Alzheimer's disease.

## Key findings

- Microglia-mediated neuroinflammation is central to Alzheimer's disease progression.
- Traditional Chinese medicine shows potential to regulate microglial phenotype and function in AD.
- Further research is needed to summarize and validate these therapeutic strategies.

## Abstract

Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by cognitive dysfunction, motor abnormalities, and memory disorders, with a persistently high and rising incidence. The pathological features of AD include the extracellular deposition of the amyloid beta peptide (Aβ), the accumulation of neurofibrillary tangles (NFTs), and neuroinflammation. Microglia (MG), the main immune cells in the central nervous system (CNS), can transform into different phenotypes. An imbalance in their phenotypic transformation may induce neuroinflammation and lead to neurological diseases, playing a central role in the onset and progression of AD.

This article aims to briefly review the key role of microglia-mediated neuroinflammation in the pathogenesis of AD and to summarize and analyze the strategies of traditional Chinese medicine (TCM) for targeting microglia in AD treatment.

Literature review and analysis were conducted to summarize the role of microglia-mediated neuroinflammation in AD pathogenesis and to collate TCM therapeutic strategies aimed at modulating microglia.

Microglia-mediated neuroinflammation plays a central role in the pathological progression of AD. TCM demonstrates potential in intervening in AD neuroinflammation by regulating the microglial phenotype and function. These related therapeutic strategies warrant further summary and analysis.

## Linked entities

- **Diseases:** Alzheimer's disease (MONDO:0004975)

## Full-text entities

- **Genes:** APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}
- **Diseases:** AD (MESH:D000544), memory disorders (MESH:D008569), neuroinflammation (MESH:D000090862), NFTs (MESH:D055956), motor abnormalities (MESH:D000014), neurodegenerative disease (MESH:D019636), cognitive dysfunction (MESH:D003072), neurological diseases (MESH:D020271)
- **Chemicals:** Traditional (-)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12620364/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12620364/full.md

## References

88 references — full list in the complete paper: https://tomesphere.com/paper/PMC12620364/full.md

---
Source: https://tomesphere.com/paper/PMC12620364